Literature DB >> 12426799

Guidelines for the management of rheumatoid arthritis: 2002 update.

Grace Newsome1.   

Abstract

Rheumatoid arthritis (RA) is a progressive polyarthritis that is responsible for over nine million office visits annually. It is likely that most nurse practitioners will care for one or more patients with RA because approximately 1% of the adult population is affected by this disabling disorder. The guideline reviewed in this month's column describes the recommended care of patients who have been previously diagnosed with RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426799     DOI: 10.1111/j.1745-7599.2002.tb00072.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  9 in total

1.  Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways.

Authors:  Mark J Crabtree; Amy L Tatham; Ashley B Hale; Nicholas J Alp; Keith M Channon
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

2.  Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.

Authors:  Marieke Voshaar; Johanna Vriezekolk; Sandra van Dulmen; Bart van den Bemt; Mart van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2016-10-21       Impact factor: 2.362

3.  Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.

Authors:  Yi Yang; Kaisha C George; Wei-Feng Shang; Rui Zeng; Shu-Wang Ge; Gang Xu
Journal:  Drug Des Devel Ther       Date:  2017-04-24       Impact factor: 4.162

4.  Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network.

Authors:  Jean-Hugues Salmon; Jean-Guillaume Letarouilly; Vincent Goëb; Lukshe Kanagaratnam; Pascal Coquerelle; Marie-Hélène Guyot; Eric Houvenagel; Nicolas Lecuyer; Laurent Marguerie; Gauthier Morel; Guy Baudens; Elisabeth Gervais; René-Marc Flipo
Journal:  J Clin Med       Date:  2020-05-19       Impact factor: 4.241

5.  Ranking facilitators and barriers of medication adherence by patients with inflammatory arthritis: a maximum difference scaling exercise.

Authors:  M J H Voshaar; J E Vriezekolk; A M van Dulmen; B J F van den Bemt; M A F J van de Laar
Journal:  BMC Musculoskelet Disord       Date:  2021-01-06       Impact factor: 2.362

6.  Fibronectin-1 is a dominant mechanism for rheumatoid arthritis via the mediation of synovial fibroblasts activity.

Authors:  Jie Yang; Yan Zhang; Jingqi Liang; Xinquan Yang; Liang Liu; Hongmou Zhao
Journal:  Front Cell Dev Biol       Date:  2022-09-26

7.  Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients.

Authors:  Xue-Mei Jin; Joongyub Lee; Nam-Kyong Choi; Jong-Mi Seong; Ju-Young Shin; Ye-Jee Kim; Mi-Sook Kim; Bo Ram Yang; Byung-Joo Park
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

8.  Rheumatoid arthritis patients' experience of climate care.

Authors:  Katrin Vaks; Rita Sjöström
Journal:  J Exerc Rehabil       Date:  2015-12-31

9.  Repeatability and Reliability of the Rheumatoid Arthritis Foot Disease Activity Index in Spanish Patients: A Transcultural Adaptation.

Authors:  Eva María Martínez-Jiménez; Héctor Pereiro-Buceta; Patricia Palomo-López; Emmanuel Navarro-Flores; Ana María Jiménez-Cebrián; Marta Elena Losa-Iglesias; Ricardo Becerro-De-Bengoa-Vallejo; Daniel López-López
Journal:  Biology (Basel)       Date:  2021-12-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.